Table II.

Characteristics of the 8 infants in whom a respiratory virus was detected by multiplex PCR testing

Sites	GA, wk	Weight, g	Sex	Age (d) and weight (g) at sepsis evaluation	Clinical manifestations	Maximum respiratory support	Date of detection	Virus (test)	Antibiotic use, d	Diagnosis (infectious)
PMH	27	900	M	130/4115	Fever, tachypnea, retractions, feeding intolerance	Nasal cannula	2/16/2012	Coronavirus HKU1∗	Gentamicin (7)/Ampicillin (2)	None
PMH	26	900	F	40/1510	Apnea, tachypnea, retractions, rhinorrhea, hematochezia‡	Nasal cannula	3/02/2012	Rhinovirus∗,†	Gentamicin (4)/Ampicillin (3)/Oxacillin (4)	None
PMH	29	1150	F	52/2410	Hypothermia, apnea, bradycardia, tachypnea, retractions, feeding intolerance, emesis‡	Mechanical ventilation	7/10/2012	Parainfluenza 3∗,†	Gentamicin (8)/Oxacillin (8)	Pneumonia
PMH	25	760	M	62/1885	Hypothermia, apnea, bradycardia, tachypnea, retractions, rhinorrhea, congestion‡	Mechanical ventilation	9/23/2012	Coronavirus OC43∗	Gentamicin (6)/Oxacillin (2)	Urinary tract infection
PMH	31	1250	F	15/1500	Apnea, retractions, tachycardia, congestion‡	Nasal cannula	10/03/2012	Enterovirus/rhinovirus†	Gentamicin (3)/Oxacillin (3)	None
PMH	29	1210	M	42/2615	Apnea, tachypnea, retractions, tachycardia, cough‡,§	Nasal cannula	1/31/2013	Parainfluenza 3∗,†	Gentamicin (2)/Oxacillin (2)	Pneumonia
WIH	34	2705	M	6/2620	Tachypnea, hematochezia	None	7/20/2012	Rhinovirus∗	Gentamicin (2)/Ampicillin (2)/Acyclovir (2)	None
WIH	26	420	F	36/1030	Apnea‡,§	Mechanical ventilation	11/23/2012	Enterovirus/rhinovirus†	Gentamicin (1)/Oxacillin (4)/Fluconazole (6)	None

F, female.

^∗GenMark eSensor.

^†Luminex xTag.

^‡Tested for respiratory virus by provider (PMH, direct fluorescent antibody test; WIH, Luminex xTag).

^§Respiratory virus detected by provider testing at birth hospital.